{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T12:41:38Z","timestamp":1784292098490,"version":"3.55.0"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T00:00:00Z","timestamp":1598832000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s11255-020-02621-9","type":"journal-article","created":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T17:02:50Z","timestamp":1598893370000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy and safety of alvimopan use in benign urinary tract reconstruction"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8098-901X","authenticated-orcid":false,"given":"Patrick","family":"Hensley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Rasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ziada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Strup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clyde","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Ruf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,31]]},"reference":[{"issue":"10","key":"2621_CR1","first-page":"574","volume":"33","author":"GI Erowele","year":"2008","unstructured":"Erowele GI (2008) Alvimopan (entereg), a peripherally acting mu-opioid receptor antagonist for postoperative ileus. P T 33(10):574\u2013583","journal-title":"P T"},{"issue":"5","key":"2621_CR2","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1097\/DCR.0b013e318249fc78","volume":"55","author":"PG Vaughan-Shaw","year":"2012","unstructured":"Vaughan-Shaw PG, Fecher IC, Harris S, Knight JS (2012) A meta-analysis of the effectiveness of the opioid receptor antagonist alvimopan in reducing hospital length of stay and time to GI recovery in patients enrolled in a standardized accelerated recovery program after abdominal surgery. Dis Colon Rectum 55(5):611\u2013620. https:\/\/doi.org\/10.1097\/DCR.0b013e318249fc78","journal-title":"Dis Colon Rectum"},{"issue":"1","key":"2621_CR3","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.juro.2014.01.097","volume":"192","author":"S Daneshmand","year":"2014","unstructured":"Daneshmand S, Ahmadi H, Schuckman AK et al (2014) Enhanced recovery protocol after radical cystectomy for bladder cancer. J Urol 192(1):50\u201355. https:\/\/doi.org\/10.1016\/j.juro.2014.01.097","journal-title":"J Urol"},{"key":"2621_CR4","unstructured":"Chang S, Bochner B, Chou R, Driecer R, Kamat A, Lerner S. Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA\/ASCO\/ASTRO\/SUO Guideline (2017) - American Urological Association.; 2017. Accessed March 24, 2020. https:\/\/www.auanet.org\/guidelines\/bladder-cancer-non-metastatic-muscle-invasive-guideline"},{"issue":"5","key":"2621_CR5","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1016\/S0022-5347(05)65074-4","volume":"167","author":"SS Chang","year":"2002","unstructured":"Chang SS, Cookson MS, Baumgartner RG, Wells N, Smith JA (2002) Analysis of early complications after radical cystectomy: results of a collaborative care pathway. J Urol 167(5):2012\u20132016","journal-title":"J Urol"},{"issue":"2","key":"2621_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/iju.12232","volume":"21","author":"F Roghmann","year":"2014","unstructured":"Roghmann F, Trinh Q-D, Braun K et al (2014) Standardized assessment of complications in a contemporary series of European patients undergoing radical cystectomy. Int J Urol 21(2):143\u2013149. https:\/\/doi.org\/10.1111\/iju.12232","journal-title":"Int J Urol"},{"issue":"4","key":"2621_CR7","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10147-018-1245-z","volume":"23","author":"M Hirobe","year":"2018","unstructured":"Hirobe M, Tanaka T, Shindo T et al (2018) Complications within 90 days after radical cystectomy for bladder cancer: results of a multicenter prospective study in Japan. Int J Clin Oncol 23(4):734\u2013741. https:\/\/doi.org\/10.1007\/s10147-018-1245-z","journal-title":"Int J Clin Oncol"},{"key":"2621_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/14651858.CD012111.pub2","volume":"2017","author":"S Sultan","year":"2017","unstructured":"Sultan S, Coles B, Dahm P (2017) Alvimopan for recovery of bowel function after radical cystectomy. Cochrane Database Syst Rev 2017:5. https:\/\/doi.org\/10.1002\/14651858.CD012111.pub2","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2621_CR9","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.eururo.2014.02.036","volume":"66","author":"CT Lee","year":"2014","unstructured":"Lee CT, Chang SS, Kamat AM et al (2014) Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trial. Eur Urol 66(2):265\u2013272. https:\/\/doi.org\/10.1016\/j.eururo.2014.02.036","journal-title":"Eur Urol"},{"key":"2621_CR10","unstructured":"FDA Label for ENTEREG\u00ae (alvimopan) Capsules. Published online 2007. Accessed April 2, 2020. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/021775lbl.pdf"},{"issue":"5","key":"2621_CR11","first-page":"9473","volume":"25","author":"SG Erpelding","year":"2018","unstructured":"Erpelding SG, Dugan A, Isharwal S, Strup S, James A, Gupta S (2018) Cystectomy for benign disease: readmission, morbidity, and complications. Can J Urol 25(5):9473\u20139479","journal-title":"Can J Urol"},{"issue":"4","key":"2621_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.5173\/ceju.2014.04.art4","volume":"67","author":"JP Manger","year":"2014","unstructured":"Manger JP, Nelson M, Blanchard S, Helo S, Conaway M, Krupski TL (2014) Alvimopan: a cost\u2013effective tool to decrease cystectomy length of stay. Cent European J Urol 67(4):335\u2013341. https:\/\/doi.org\/10.5173\/ceju.2014.04.art4","journal-title":"Cent European J Urol"},{"issue":"4","key":"2621_CR13","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1111\/iju.12284","volume":"21","author":"JA Cohn","year":"2014","unstructured":"Cohn JA, Large MC, Richards KA, Steinberg GD, Bales GT (2014) Cystectomy and urinary diversion as management of treatment-refractory benign disease: the impact of preoperative urological conditions on perioperative outcomes. Int J Urol 21(4):382\u2013386. https:\/\/doi.org\/10.1111\/iju.12284","journal-title":"Int J Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02621-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02621-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02621-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,31]],"date-time":"2021-08-31T00:20:22Z","timestamp":1630369222000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02621-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,31]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["2621"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02621-9","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,31]]},"assertion":[{"value":"2 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflicts of interest or competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}